Cell Signaling Technology Executive and Leadership Team

Matthew Curran, the Chief Financial Officer & Board Member at Cell Signaling Technology, directs all financial operations and strategic fiscal planning. Curran oversees budgeting, financial reporting, and investment strategies, ensuring the company's fiscal health and sustainable growth. This leadership position involves managing financial resources to support the development and distribution of essential research products, including antibodies and ELISA kits, used in studying cell signaling pathways. As a Board Member, Matthew Curran contributes to high-level corporate governance and strategic decision-making, aligning financial objectives with the company's mission to advance scientific discovery. By optimizing financial performance and managing risk, the Chief Financial Officer & Board Member ensures Cell Signaling Technology can continue its vital work in the life sciences sector, supporting researchers globally.

Craig Thompson, the Chief Operating Officer at Cell Signaling Technology, directs all operational functions critical to the company's mission of supporting scientific discovery. Overseeing the production and distribution of antibodies, ELISA kits, and proteomic reagents, Craig Thompson ensures the seamless delivery of high-quality products to researchers worldwide. This leadership role involves optimizing internal processes and supply chain logistics to meet the dynamic demands of the life sciences industry. By managing the company's operational infrastructure, the Chief Operating Officer drives efficiency and scalability, directly supporting the advancement of research into cell signaling pathways that impact human health. Thompson's focus remains on enhancing operational excellence across all departments, ensuring Cell Signaling Technology maintains its position as a premier provider of research tools.

Thomas Barry, the Chief of Staff at Cell Signaling Technology, orchestrates strategic initiatives and ensures alignment across executive functions. Barry manages critical projects and facilitates communication between departments, driving the company's overarching goals forward. This role involves close collaboration with the Chief Scientific Officer and Chief Financial Officer to translate research insights into actionable business strategies. By streamlining internal operations and fostering cross-functional synergy, Thomas Barry enhances the company's ability to deliver innovative products and services to the life sciences community. The Chief of Staff's responsibilities include optimizing resource allocation and supporting the executive team in navigating complex market dynamics, thereby reinforcing Cell Signaling Technology's commitment to scientific discovery and human health research.

Roberto Polakiewicz, the Chief Scientific Officer at Cell Signaling Technology, leads the company's scientific vision and research and development efforts. Polakiewicz guides the innovation of new products and services, including cutting-edge proteomic kits and ChIP kits, essential for understanding cell signaling pathways. This role involves directing scientific strategy to ensure Cell Signaling Technology remains at the forefront of life sciences research, providing scientists with the tools needed for discovery. By fostering a culture of scientific excellence, Roberto Polakiewicz ensures the integrity and quality of the company's reagents and kits, which are critical for advancing human health research. The Chief Scientific Officer's expertise drives the development of solutions that empower researchers globally, reinforcing the company's commitment to supporting scientific breakthroughs.